To study the possible importance of the low density lipoprotein (LDL) receptor in regulating the degree of postprandial lipemia, a cholesterol-rich fat emulsion was infused into the duodenum of subjects who were divided into four groups based on the expected variation in the expression of the LDL receptor: young men (n=ll), elderly men (n=7), male patients on estrogen therapy (n-5), and patients with familial hypercholesterolemia (n=9). In familial hypercholesterolemia, fasting plasma levels of lipoproteins of d< 1.006 g/ml, intermediate density lipoproteins, and LDLs were increased. During the fat infusion, the cholesterol and triglyceride contents in the d< 1.006 g/ml fraction increased to a similar extent in all groups, whereas a concomitant reduction of LDL cholesterol levels was observed. The degree of the decrease in LDL cholesterol was positively correlated with the observed increase in triglycerides in the </< 1.006 g/ml fraction. There were no signs of accumulation of intermediate density lipoproteins during infusion in any of the groups studied. The results indicate that the capacity for clearance of chylomicrons and chylomicron remnants is not affected by variation in LDL receptor expression. {Arteriosclerosis and Thrombosis 1991;ll:827-837)
Metabolism of Lipoprotein
To study the possible importance of the low density lipoprotein (LDL) receptor in regulating the degree of postprandial lipemia, a cholesterol-rich fat emulsion was infused into the duodenum of subjects who were divided into four groups based on the expected variation in the expression of the LDL receptor: young men (n=ll), elderly men (n=7), male patients on estrogen therapy (n-5), and patients with familial hypercholesterolemia (n=9). In familial hypercholesterolemia, fasting plasma levels of lipoproteins of d< 1.006 g/ml, intermediate density lipoproteins, and LDLs were increased. During the fat infusion, the cholesterol and triglyceride contents in the d< 1.006 g/ml fraction increased to a similar extent in all groups, whereas a concomitant reduction of LDL cholesterol levels was observed. The degree of the decrease in LDL cholesterol was positively correlated with the observed increase in triglycerides in the </< 1.006 g/ml fraction. There were no signs of accumulation of intermediate density lipoproteins during infusion in any of the groups studied. The results indicate that the capacity for clearance of chylomicrons and chylomicron remnants is not affected by variation in LDL receptor expression. {Arteriosclerosis and Thrombosis 1991;ll:827-837) I n normal humans, the transport processes of both endogenous and exogenous fat and cholesterol are very efficient. 12 In the fasting state, endogenous fat is secreted from the liver in very low density lipoproteins (VLDLs), which are converted by the endothelial enzyme lipoprotein lipase to VLDL remnants, or intermediate density lipoproteins (IDLs). 1 -2 These are either taken up directly by the liver or catabolized further to low density lipoproteins (LDLs). Both IDL and LDL are believed to be cleared predominantly by specific hepatic lipoprotein receptors recognizing apolipoprotein (apo) B and apo E (apo B,E or LDL receptors). In patients with familial hypercholesterolemia (FH), an autoso-mal dominant disorder characterized by elevated plasma LDL levels, reduced LDL receptor activity, and premature atherosclerosis, 3 accumulation of IDL particles occurs in the severe homozygous form of the disease. It is, however, less clear whether these lipoproteins also accumulate in the more common heterozygous form of FH. This possibility is of particular interest since IDLs are considered to be potentially atherogenic. 1 -3 In the postprandial state, cholesterol and fat are absorbed, transported in the chylomicron fraction, and eventually cleared as chylomicron remnants. Substantial amounts of dietary lipid can be absorbed and assimilated with relatively minor effects on the total levels of plasma cholesterol and triglycerides. 4 The chylomicron remnant fraction is considered to be potentially atherogenic. 5 The clearance of these particles seems to vary, depending on the individual apo E phenotype. 67 In some situations such as dysbetalipoproteinemia (type III hyperlipoproteinemia), the clearance of chylomicron remnants is delayed considerably as a consequence of the presence of a variant apo E with reduced affinity for the lipoprotein receptors. 8 can also be detected in the fasting state as )3-VLDL. The high propensity for early atherosclerosis in type III hyperlipoproteinemia has been ascribed to the atherogenicity of the /3-VLDL fraction and particularly of the chylomicron remnants. Recently, the concept of specific chylomicron remnant receptors in the liver has been questioned, and the possibility that LDL receptors are of major importance in the clearance of chylomicron remnants has been suggested. 11 If so, detailed studies of the elimination of intestinal lipoproteins in subjects with varying expression of LDL receptors would reveal differences in chylomicron and chylomicron remnant clearance. Because both chylomicron remnants and IDL have been implicated as potentially atherogenous lipoprotein particles, we decided to study the effects of a heavy intestinal load of fat and cholesterol on the different lipoprotein fractions in subjects with assumed differences in LDL receptor activity. Specifically, we studied four groups of subjects: 1) young healthy male controls; 2) elderly healthy men who had been shown to have increased LDL levels due to a reduced fractional catabolic rate of LDL 1213 ; 3) patients with heterozygous FH who had a reduced receptor-mediated clearance of LDL 3 ; and 4) elderly men with prostatic cancer who were on chronic estrogen therapy, which is known to profoundly stimulate LDL clearance via induction of hepatic LDL receptors. 14 In the present investigation, we report our studies of the role of LDL receptor activity in the clearance of the chylomicron remnant fraction. We were not able to demonstrate any difference in the clearance of postprandial lipoproteins attributable to the variation in LDL receptor expression, despite a heavy and prolonged load of dietary fat and cholesterol.
Methods

Subjects
A total of 32 subjects volunteered for the present study (Table 1) . Two groups of healthy controls were studied: 11 young men aged 26-42 years and seven elderly men aged 67-82 years. Body weights were normal (relative body weight <105%) in all subjects studied, and none of the controls were taking any medication. Altogether, nine patients (five men and four women) with heterozygous FH between 31 and 62 years old were studied. Tendon xanthomas were present in eight patients, and in all patients pedigree analysis (including presence of tendon xanthomas in at least one primary relative) was consistent with the presence of FH. 3 The diagnosis of heterozygous FH was confirmed by determination of high-affinity iodine-125-labeled LDL degradation in isolated mononuclear blood cells incubated in lipoproteindeficient serum for 3 days 15 : all patients had values less than 50% of control (range, 6-49%). Four of these patients had evidence of ischemic heart disease, and two were on continuous treatment with )3-blocking agents or diuretics. No lipid-lowering therapy except diet had been given to the FH patients for at least 1 month before the study. Five male patients (65-72 years) with prostatic carcinoma who had been treated for more than 1 year with estrogens (150 /Ag/day p.o. ethinyl estradiol and 80 mg/mo i.m. polyestradiol phosphate) and who were in stable clinical condition were investigated. One of these patients was on /3-blocker therapy for angina pectoris. None of the participants had clinical or laboratory evidence of diabetes mellitus or of thyroid, blood, liver, or kidney disease. Apo E phenotype was determined in 29 subjects altogether: two had phenotype 2/3; 20, 3/3; three, 4/3; and four, 4/4. All subjects gave their informed consent to participate in the study, which had been approved by the Ethical Committee of the Karolinska Institute.
Experimental Procedure
The experiments were started at 8 AM after a 12-hour fast. The preceding evening, the subjects swallowed a perfusion catheter equipped with a mercury-filled rubber bag at the tip. After ascertaining that the tip of the catheter was located in the duodenum, fasting blood samples were drawn into EDTA-containing tubes. A duodenal infusion of a fat emulsion (Intralipid, Kabi-Vitrum, Stockholm, Sweden), into which 12 egg yolks had been mixed (final volume, 500 ml), was then started at a rate of 1.4 ml/min by use of a peristaltic pump (model 928 volumetric infusion pump, IMED, Abington, Oxon, England). The composition of the cholesterol-fat mixture is detailed in Table 2 .
Blood samples were drawn at 3 and 6 hours after the start of the experiment. The infusion was termi- nated after obtaining the 6-hour sample. Fasting blood samples were again obtained the following morning, 24 hours after the start of the infusion.
All subjects tolerated the perfusion well. No side effects except tiredness, heavy satiety, and a feeling of warmth were noted. Body temperature, measured rectally, increased from 36.7±0.1°C to 37.1±0.1°C (/><0.01) during the 6-hour infusion period.
Analytical Procedure
The blood samples were immediately placed on ice and centrifuged at 3,000 rpm for 20 minutes at 4°C. Two portions of the plasma (4 ml each) were subjected to single-spin ultracentrifugation in a Beckman 40.3 rotor at 40,000 rpm for 20 hours at 4°C with a Beckman L5 -75 ultracentrifuge 16 (Beckman Instruments, Palo Alto, Calif.). Parallel ultracentrifugations were always performed at two different densities. NaBr was added to one of the tubes to give a final density of 1.020 g/ml, whereas the parallel tube was kept at a density of 1.006 g/ml. The tubes were sliced, and the top and bottom fractions were analyzed for cholesterol and triglycerides by enzymatic procedures (Boehringer-Mannheim GmbH, Mannheim, FRG). By this procedure, the plasma content of cholesterol and triglycerides in the d< 1.006 g/ml fraction (triglyceride-rich lipoproteins; i.e., VLDL plus chylomicrons), the d<1.02 g/ml fraction (triglyceride-rich lipoproteins plus IDL) as well as the d> 1.006 g/ml and the d>1.02 g/ml fractions were determined. By difference, the content in the 1.006-1.020 g/ml density fraction, that is, the fraction corresponding to IDL, was calculated. Cholesterol and triglyceride levels in the high density lipoprotein fraction were determined after precipitation of apo B-containing particles in the infranatant fraction with phosphotungstic acid. 17 Plasma samples, as well as the top and bottom fractions resulting from the ultracentrifugation analysis, were subjected to agarose gel electrophoresis and subsequently stained for lipid content. 18 Serum samples were drawn in parallel with the plasma samples and analyzed for apo A-I and apo B by immunonephelometry (Orion Diagnostica, Espoo, Finland). Apo E phenotyping was performed on serum by Western blotting as described by Menzel and Utermann. 19 The high-affinity (receptor-mediated) degradation of [ 125 I]LDL by isolated mononuclear white blood cells was determined as previously described. 20 For each patient with heterozygous FH, multiple petri dishes containing 2xlO 6 cells in 1 ml RPMI-1640 medium containing 10% human lipoproteindeficient serum were preincubated for different time periods at 37°C to induce LDL receptor activity as described by Bilheimer et al. 15 At time zero and after 1,2, and 3 days of preincubation, 25 /Ag [ 
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The fatty acid composition of the cholesterol-fat mixture used for infusion was analyzed by gas-liquid chromatography, 21 and the triglyceride and cholesterol contents were analyzed as described above by enzymatic procedures after extraction with chloroform/methanol (2:1, vol/vol). Phospholipid contents in the same extract were determined according to Rouser et al. 22 The protein content of the infusion mixture was analyzed by the Lowry procedure. 23 To correlate the changes in the different lipoproteins to the metabolism of chylomicron remnants during the intestinal infusion, 150,000 units aqueous vitamin A (Arovit, Roche, Nutley, N.J.) was mixed into the cholesterol-fat mixture administered to two normal subjects. In this experiment, retinyl palmitate levels in plasma as well as in the different lipoprotein fractions were then analyzed in subdued light by high-performance liquid chromatography in the samples drawn at 0, 3, 6, and 24 hours (detection limit of assay, 0.5 /rniol/l). As shown in Table 3 , essentially all the plasma retinyl palmitate was present in the d< 1.006 g/ml fraction, that is, triglyceride-rich lipoproteins. During infusion, the triglyceride-rich lipoprotein retinyl palmitate levels increased, and this fraction constituted the majority of the increase in plasma retinyl palmitate levels. It has previously been well established that retinyl palmitate specifically traces particles of intestinal origin, and the vitamin A loading test has been extensively validated in studies of postprandial lipemia. 8 These results therefore establish that the particles originating from the intestine, that is, chylomicrons and chylomicron remnants, were found in the triglyceride-rich lipoprotein fraction of the separation system used in the present study.
Statistical Methods
Data are presented as mean±SEM. The significance of differences was evaluated by analysis of variance; /?<0.05 by two-tailed tests was considered statistically significant. For evaluation of correlations, stepwise multiple linear regression analysis was performed when enough observations were present. In other cases, simple linear regression analysis was used. To quantify the magnitude of the postprandial response, the area under the response curve was used. This area under the curve was denned by a line connecting the observed values at 0-6 hours and a line parallel to the x axis originating at the value corresponding to the 0-hour time point.
Results
Lipoprotein Changes Among Young Normals
In response to the duodenal infusion of the cholesterol-fat mixture, plasma triglyceride levels increased drastically in all young normals. This elevation was almost entirely due to an increase in the d< 1.006 g/ml fraction, that is, triglyceride-rich lipoproteins (VLDL plus chylomicrons), but HDL triglyceride levels also increased somewhat (Figure 1 ). There was no significant difference between the 3-hour and 6-hour levels in triglyceride-rich lipoprotein triglycerides, and no significant changes were seen in LDL or IDL triglycerides throughout the experiment (Table 4) . After termination of the infusion, the increased plasma triglyceride content cleared entirely during the following 18 hours, and at 24 hours plasma, triglyceride-rich lipoproteins, and HDL triglyceride levels showed a tendency to be lower compared with pretreatment values. In the young normals, plasma cholesterol levels also tended to increase slightly after 3 hours, and a significant maximum was observed after 6 hours ( Figure 1 ). This increase was entirely accounted for by an increase in triglyceride-rich lipoprotein cholesterol (/J<0.001 after 3 and 6 hours). In contrast, the levels of LDL cholesterol decreased during the infusion (/?<0.01 at 3 hours). HDL cholesterol levels were also significantly reduced after 3 hours of infusion (p<0.05) but increased to pretreatment values after 6 hours. Very low levels of IDL cholesterol could be detected, and they remained unchanged during the infusion. These changes induced by the infusion reverted to baseline levels on the following day.
Analysis of the plasma lipoproteins by agarose gel electrophoresis confirmed the increase of lipid-staining material in the d< 1.006 g/ml fraction ( Figure 2) . Inspection of the electrophoretograms of the d< 1.006 g/ml lipoproteins did not reveal any lipidstaining material with /3-mobility either in this fraction or in the d< 1.020 g/ml fraction, indicating the absence of detectable amounts of /3-VLDL. The increase in triglyceride-rich lipoproteins during the infusion corresponded to an increase in apo B levels (Table 5 ). In contrast, the levels of apo A-I were virtually unchanged during the whole experiment.
Lipoprotein Changes in Elderly Normals
As demonstrated previously, 1213 fasting plasma total and LDL cholesterol levels were higher in the Values are mean±SEM and are in mmol/1. FH, familial hypercholesterolemia. Significantly different from time 0 at the following levels: */><0.05, tp<0.01, Significantly different from corresponding controls at the following levels (see Table 4 ): §p<0.05, ||p<0.01,11/7 < 0.001.
elderly normal controls compared with young normals (Table 4) . No other differences were observed between the two groups of men in the fasting state. In response to the duodenal infusion, triglycerides increased due to an increase in the d< 1.006 g/ml triglycerides after both 3 and 6 hours (Table 4) . HDL triglycerides were also elevated after 3 hours. In contrast to the young normals, no change was seen in plasma total cholesterol. However, cholesterol in triglyceride-rich lipoproteins was significantly increased after both 3 and 6 hours of infusion. On the contrary, both LDL and HDL cholesterol were significantly decreased after 3 hours. IDL cholesterol levels were initially low and did not change during the infusion (Table 4) . Compared with those in young normals, apo B levels were significantly higher in elderly normals both initially and after 3 and 6 hours of infusion ( Table  5 ). The levels of apo A-I were slightly higher in the elderly and increased somewhat during infusion.
Lipoprotein Changes in Familial Hypercholesterolemia Patients
The reduced LDL receptor activity in FH patients was reflected in their fasting lipid and lipoprotein levels ( Table 4) . Total and LDL cholesterol, as well as total triglycerides, were higher in FH patients. Of particular interest was the fact that substantial amounts of IDL could be demonstrated in fasting plasma in all FH patients (Table 4, Figure 3 ), indicating either a reduced clearance capacity or an increased production of IDL (or VLDL remnants). During duodenal infusion, plasma triglyceride levels rose significantly, with the major increase in the triglyceride-rich lipoprotein fraction (Table 4) . HDL triglycerides were also significantly higher after 6 hours (p<0.05) and contributed to the overall increase in triglycerides in plasma. Despite the heavy load of fat, IDL as well as LDL triglycerides remained unchanged during the experiment. Fasting samples the next day showed a significantly lower level of plasma triglycerides (/?<0.05) compared with the fasting pretreatment levels.
Although fasting plasma cholesterol levels were highly elevated in the FH patients, they did not change during the duodenal infusion. The cholesterol levels in the d< 1.006 g/ml fraction rose, whereas there was a corresponding drop in LDL and to some extent also in HDL cholesterol (Table 4 ). In contrast, the infusion did not result in any changes in IDL in FH patients, apart from a significant reduction in IDL cholesterol at 24 hours (/><0.01). This was supported by the lack of further accumulation of j3-lipoproteins in either the d< 1.006 or the d< 1.020 g/ml fraction during infusion (Figure 3 ). The levels of LDL cholesterol tended to be slightly elevated the next morning compared with pretreatment values. HDL cholesterol, which was slightly depressed during the infusion, was increased after 24 hours (p<0.05). Overall, the pattern of increase in triglyceride-rich lipoprotein lipids was similar in the FH group and the young normals ( Figure 4 ). In concert with the changes in triglyceride-rich lipoproteins, apo B levels increased (/?<0.05) after 6 hours. Apo A-I, on the other hand, remained unaffected during the infusion (Table 5 ). The only significant difference between men and women with FH was in the apo A-I level, for which women had higher levels (data not shown).
Lipoprotein Changes in Estrogen-Treated Men
To further explore the possible role of LDL receptor expression in postprandial lipoprotein metabolism, we studied men with prostatic cancer who were on treatment with pharmacological doses of estrogen. As we have reported earlier, 14 baseline levels of HDL cholesterol, apo A-I, and plasma triglyceride were higher and LDL cholesterol levels were lower than in age-matched controls (Tables 4 and 5 ). In response to duodenal infusion of the cholesterol-fat mixture, plasma triglycerides increased, and this was entirely due to an increase in the d< 1.006 g/ml fraction (Table 4, Figure 5 ). Triglycerides in the other lipoprotein fractions were unaffected during the infusion. During the following 18 hours, triglyceride levels returned to baseline levels.
Total plasma cholesterol levels were almost unaffected during the infusion. There was, however, a significant increase in triglyceride-rich lipoprotein cholesterol and a slight but significant decrease in LDL cholesterol after 3 hours. This was also accompanied by a decrease in HDL cholesterol that was profound and highly statistically significant after both 3 and 6 hours. It is noteworthy that this decrease was more pronounced in the patient group than in the age-matched controls, and it may be connected with the change in HDL metabolism induced by estrogens.
Statistical Analysis
To evaluate possible metabolic interrelations between the various lipoprotein fractions in response to the fat infusion, we performed a series of regression analyses. The fall in LDL cholesterol during the infusion was positively correlated with the rise in triglycerides in the d< 1.006 g/ml fraction (r=0.72, p<0.02) by multiple stepwise regression analysis. Simple linear regression was performed in the separate groups, as there were too few data to perform multiple regression analysis. There was a clear correlation between the decrease in LDL cholesterol and the increase in triglycerides in the d< 1.006 g/ml lipoprotein fraction in the young normals (r=0.73, /><0.02) as well as in FH patients (r=0.79,/><0.02). Furthermore, multiple stepwise regression analysis of the data for the entire study group showed that the decrease in LDL cholesterol was also correlated with baseline values of LDL cholesterol (r=0.56) and plasma triglycerides (r=0.70).
In the estrogen-treated group, simple linear regression analysis showed that the significant decrease in HDL cholesterol was correlated with the increase in cholesterol in the d< 1.006 g/ml lipoprotein fraction (r=0.90, p=0.05) and the decrease in LDL cholesterol (r=0.91,/><0.05).
The area under the curve was calculated for 0-6 hours, with the 0-hour values as baseline, as described above. The results in the area under the curve for cholesterol and triglycerides in the d< 1.006 g/ml fraction are shown in Table 6 . No statistically significant differences were noted among FH patients, estrogen-treated elderly men, and the two control groups. This indicates that the magnitude in the postprandial response was similar in all groups. No significant difference with regard to apo E phenotypes was found either in basal plasma lipid levels or in the postprandial response. The area under the curve corresponding to the d< 1.006 g/ml fraction Values are mean±SEM and are areas under the 0-6-hour curve for duodenal infusion.
FH, familial hypercholesterolemia.
was positive, whereas the area under the curve for IDL cholesterol was very small (and negative) in all groups during the infusion. When the area under the curve was calculated for the other lipoprotein fractions, a significant drop in HDL cholesterol in the estrogen-treated elderly men occurred compared with elderly normals (/?<0.05), but apart from this no statistically significant differences among the groups were found. Although the different lipoprotein fractions were not isolated during the experiment, the cholesterol to triglyceride ratio in the various density fractions might be valuable as an indication of compositional changes. During infusion, the cholesterol to triglyceride ratio in triglyceride-rich lipoproteins decreased in normals and FH patients (Table 7) . FH patients had an elevated ratio compared with normals on all occasions. No significant differences between the two groups of elderly men occurred during the infusion. However, at 24 hours the cholesterol to triglyceride ratio was significantly lower compared with the pretreatment value. 24 A major new finding in the present study was the demonstration (under baseline conditions) of the existence of particles in the IDL density range in all nine FH heterozygotes ( Figure 3 , Table 4 ). In addition, VLDL cholesterol and VLDL triglycerides were also increased in the FH group. These data suggest an important role for the LDL receptor in the clearance of VLDL and IDL and indicate a potential importance of IDL particles for the premature development of atherosclerosis in FH patients. However, these findings did not necessarily imply that clearance of remnants produced during the postprandial phase might be compromised in these patients.
To study the effects of a continuous heavy load of dietary fat and cholesterol, we used a standardized technique of duodenal infusion. To ascertain optimal absorption, relatively large amounts of phospholipids were infused, and this may obviously create a somewhat unphysiological situation. Although interindividual variation of cholesterol absorption may still be present, the problem of variation in gastric emptying is avoided with the present approach, and a steadystate situation with regard to the flux of triglyceriderich lipoproteins (VLDL plus chylomicrons plus chylomicron remnants) can be obtained. 4 It is of particular interest that despite the reduced expression of LDL receptors affecting the clearance of VLDL remnants, the patients with heterozygous FH did not display any abnormality in their clearance of the d< 1.006 g/ml lipoproteins. This demonstrates that the capacity to clear chylomicron remnants is normal in heterozygous FH. The results of the present study thus clearly underscore the differences in metabolism of endogenous and exogenous lipoproteins in humans. With less drastic fat loads, a normal clearance of chylomicrons has been suggested to occur in at least a few homozygous FH patients 3 ; in the Watanabe heritable hyperlipidemic rabbit, the clearance of chylomicron remnants is also normal. 25 The observation that type Ila hyperlipoproteinemic patients have a lower chylomicron response during a vitamin A-fat loading test also supports the contention that the metabolism of postprandial lipoproteins is not compromised in FH patients. 8 Although a reduced number of LDL receptors in heterozygous FH might hypothetically be enough for normal clearance of chylomicron remnants, the present data support the concept of a selective removal system for chylomicron remnants, presumably a hepatic remnant receptor. 9 Further support for this hypothesis was obtained by the lack of accumulation of IDL particles in all subjects, although LDL receptor levels differed less among the other three subject groups. Also, the finding that nonchylomicron clearance is highly dependent on the individual apo E phenotype is compatible with such a theory. 6 The fact that this was not demonstrable in our study most likely results from the limited range of apo E phenotypes studied.
An intriguing finding in the present study was that LDL cholesterol fell while LDL triglycerides remained unchanged or became slightly elevated in all groups studied. Such a finding after a fat meal has previously been reported in healthy subjects. 26 In the present study, the fall in LDL cholesterol was less in normals compared with the other groups studied. The reason for this decrease in LDL cholesterol during duodenal infusion of the cholesterol-fat mixture is not self-evident, but two principal explanations may be considered. First, the production rate of LDL may have been reduced. This could occur as the result of reduced VLDL synthesis in the liver or a reduced conversion of VLDL and IDL to LDL. Apart from a fall in LDL cholesterol, calculations of the area under the curve during 0-6 hours for IDL cholesterol also showed a tendency to decrease in all groups. It is possible that the buildup of remnant particles during the fat load could saturate the enzymes responsible for hydrolysis of triglycerides and thus block the synthesis of IDL and LDL particles from VLDL. 27 This concept is supported by the fact that there was a correlation between the rise in d< 1.006 g/ml triglycerides and the drop in LDL cholesterol. In addition, the observed changes in the cholesterol to triglyceride ratio in LDL as well as in HDL could also be secondary to transfer from the triglyceride-rich lipoprotein fraction during catabolism of the triglyceride-rich lipoproteins. 28 - 30 Indeed, such changes in LDL could affect its metabolism. 28 However, there might be an alternative explanation for the decrease in LDL cholesterol levels during infusion. One possibility might indeed be increased catabolism of LDL during such a high inflow of intestinal lipoproteins. The changes in the cholesterol to triglyceride ratio within the LDL fraction might mirror important compositional changes that could influence the interaction between the LDL particles and the LDL receptor and, hence, influence clearance, as has previously been observed in model systems. 31 - 32 The finding that a more prominent decrease in LDL cholesterol during infusion was seen in subjects with lower LDL receptor activity (FH patients and elderly normals) argues against such an increased clearance, however. Another possibility to be considered is that non-receptor-mediated clearance of LDL is stimulated as a result of the fat load. The mechanism behind the decrease of LDL cholesterol observed during the infusion thus needs to be further explored.
In the present study, we have not been able to identify any of the "naturally" occurring lipoproteins in normals or FH patients as atherogenic, even after infusion of a considerable load of exogenous choles-terol. In preliminary experiments, none of the lipoprotein fractions (d< 1.006 g/ml, IDL, or LDL) caused an accumulation of cholesteryl esters in cultured mouse peritoneal macrophages. We cannot exclude long-term effects from the infusion due to other mechanisms that might affect atherogenesis, however. There is a prolonged presence of chylomicrons as well as chylomicron remnants in plasma after fat ingestion. 8 It cannot be excluded at present that modifications of the lipoproteins in the circulation or in the vicinity of the arterial wall could occur and be important in these situations. Such a modification of J3-VLDL particles has recently been demonstrated in vitro. 33 In conclusion, the tendency of normolipidemic humans to accumulate remnant particles after ingestion of large amounts of fat and cholesterol is very limited. The apparent reserve potential in the postprandial clearing mechanisms may provide an efficient protection for accumulation of potentially atherogenic particles. Also, patients with FH seem to have efficient mechanisms for clearance of such remnant particles. Instead, there was an accumulation of particles within the IDL fraction, both before and during the cholesterol-fat infusion, in FH heterozygotes. These particles might be important for the development of early atherosclerosis. This implies that FH patients have a normal "remnant" (receptor-mediated?) clearance but that the reduced numbers of functioning LDL receptors affect the catabolism of both LDL particles and LDL precursors (IDL and VLDL remnants).
